C19-Norditerpenoid Alkaloids from Aconitum szechenyianum

Bei Song,Bingliang Jin,Yuze Li,Fei Wang,Yifu Yang,Yuwen Cui,Xiaomei Song,Zhenggang Yue,Jianli Liu
DOI: https://doi.org/10.3390/molecules23051108
IF: 4.6
2018-05-08
Molecules
Abstract:Three new C<sub>19</sub>-norditerpenoid alkaloids (<b>1⁻3</b>), along with two known C<sub>19</sub>-norditerpenoid alkaloids (<b>4,5</b>), have been isolated from <i>Aconitum szechenyianum</i>. Based on extensive spectroscopic techniques (1D, 2D-NMR, IR, and MS) and chemical methods, their structures were established as szechenyianine D <b>(1)</b>, szechenyianine E (<b>2</b>), szechenyianine F (<b>3</b>), 8-<i>O</i>-methyl-14-benzoylaconine (<b>4</b>), and spicatine A (<b>5</b>). The immunosuppressive effects of compounds <b>1</b>⁻<b>5</b> were studied using a ConA-induced or LPS-induced splenocyte proliferation model. In vitro tests showed that Compounds <b>2, 4</b>, and <b>5</b> suppressed ConA-induced or LPS-induced splenocyte proliferation in a concentration-dependent manner. The CC<sub>50</sub>/IC<sub>50</sub> values of <b>2, 4,</b> and <b>5</b> suggested that these compounds were potential immunosuppressive agents for the treatment of autoimmune diseases characterized by arthritis, such as rheumatoid arthritis.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?